Order Article Reprints

Cern A, Bavli Y, Hod A, Zilbersheid D, Mushtaq S, Michael-Gayego A, Barasch D, Feinstein Rotkopf Y, Moses AE, Livermore DM, et al. Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria. Pharmaceutics. 2021; 13(12):2186. https://doi.org/10.3390/pharmaceutics13122186

Cern, Ahuva, Yaelle Bavli, Atara Hod, Daniel Zilbersheid, Shazad Mushtaq, Ayelet Michael-Gayego, Dinorah Barasch, Yael Feinstein Rotkopf, Allon E. Moses, David M. Livermore, and et al. 2021. "Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria" Pharmaceutics 13, no. 12: 2186. https://doi.org/10.3390/pharmaceutics13122186

Cern, A., Bavli, Y., Hod, A., Zilbersheid, D., Mushtaq, S., Michael-Gayego, A., Barasch, D., Feinstein Rotkopf, Y., Moses, A. E., Livermore, D. M., & Barenholz, Y. (2021). Therapeutic Potential of Injectable Nano-Mupirocin Liposomes for Infections Involving Multidrug-Resistant Bacteria. Pharmaceutics, 13(12), 2186. https://doi.org/10.3390/pharmaceutics13122186